13,541 Shares in National Research Co. (NASDAQ:NRC) Bought by Inceptionr LLC

Inceptionr LLC purchased a new position in National Research Co. (NASDAQ:NRC) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 13,541 shares of the company’s stock, valued at approximately $239,000.

Several other hedge funds have also added to or reduced their stakes in the business. Geode Capital Management LLC lifted its stake in National Research by 3.2% in the third quarter. Geode Capital Management LLC now owns 420,733 shares of the company’s stock worth $9,619,000 after purchasing an additional 13,039 shares during the last quarter. State Street Corp lifted its stake in National Research by 4.0% in the third quarter. State Street Corp now owns 363,438 shares of the company’s stock worth $8,351,000 after purchasing an additional 14,144 shares during the last quarter. QV Investors Inc. lifted its stake in National Research by 4.5% in the fourth quarter. QV Investors Inc. now owns 354,360 shares of the company’s stock worth $6,251,000 after purchasing an additional 15,370 shares during the last quarter. Bank of New York Mellon Corp lifted its stake in National Research by 88.5% in the fourth quarter. Bank of New York Mellon Corp now owns 217,212 shares of the company’s stock worth $3,832,000 after purchasing an additional 101,957 shares during the last quarter. Finally, Hotchkis & Wiley Capital Management LLC bought a new stake in National Research in the third quarter worth $3,158,000. 47.26% of the stock is owned by institutional investors.

National Research Stock Performance

National Research stock opened at $15.20 on Tuesday. The company has a quick ratio of 0.47, a current ratio of 0.47 and a debt-to-equity ratio of 1.30. The company has a market capitalization of $356.84 million, a PE ratio of 14.48 and a beta of 0.47. The firm has a fifty day simple moving average of $16.72 and a two-hundred day simple moving average of $18.78. National Research Co. has a twelve month low of $13.74 and a twelve month high of $40.69.

National Research (NASDAQ:NRC) last issued its quarterly earnings data on Monday, January 27th. The company reported $0.28 EPS for the quarter. National Research had a net margin of 17.32% and a return on equity of 66.52%.

National Research Company Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.